Biocryst Pharmaceuticals Inc (NASDAQ: BCRX)
Biocryst Pharmaceuticals Inc (BCRX) last month performance of 1.32% certainly makes it a sizzling prospect
Shaun Noe
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) flaunted slowness of -3.90% at $6.9, as the Stock market unbolted on Thursday, before settling ...
Biocryst Pharmaceuticals Inc (BCRX) is destined for greater heights as its last quarter sales were 163,350 K
Zack King
On Tuesday, Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) opened lower -1.46% from the last session, before settling in for the closing ...
No matter how cynical the overall market is, Biocryst Pharmaceuticals Inc (BCRX) performance over the last week is recorded -8.17%
Sana Meer
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) on Friday, plunged -1.34% from the previous trading day, before settling in for the closing ...
Biocryst Pharmaceuticals Inc (BCRX) EPS is poised to hit 0.04 next quarter: How Investors Can Make It Count the Most?
Steve Mayer
Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) open the trading on Wednesday, with great promise as it jumped 4.75% to $7.28, before ...
